The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 20, 2018
Filed:
Apr. 14, 2017
Applicant:
Aldeyra Therapeutics, Inc., Lexington, MA (US);
Inventors:
Thomas A. Jordan, Lexington, MA (US);
John E. Dowling, Boston, MA (US);
John Clifford Chabala, Scotch Plains, NJ (US);
Assignee:
ALDEYRA THERAPEUTICS, INC., Lexington, MA (US);
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/47 (2006.01); C07D 215/38 (2006.01); C07D 277/56 (2006.01); C07D 277/40 (2006.01); C07C 229/60 (2006.01); C07C 229/56 (2006.01); A61K 31/44 (2006.01); A61K 31/4706 (2006.01); A61K 31/435 (2006.01); A61K 31/426 (2006.01); A61K 31/423 (2006.01); A61K 31/41 (2006.01); A61K 31/4418 (2006.01); C07C 215/68 (2006.01);
U.S. Cl.
CPC ...
C07D 215/38 (2013.01); A61K 31/41 (2013.01); A61K 31/423 (2013.01); A61K 31/426 (2013.01); A61K 31/435 (2013.01); A61K 31/44 (2013.01); A61K 31/4418 (2013.01); A61K 31/47 (2013.01); A61K 31/4706 (2013.01); C07C 215/68 (2013.01); C07C 229/56 (2013.01); C07C 229/60 (2013.01); C07D 277/40 (2013.01); C07D 277/56 (2013.01);
Abstract
Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.